Back
  1. Successful Monitoring of Gaucher Disease

Successful Monitoring of Gaucher Disease

Dr. rer. nat. Claudia Cozma, MD
June 27, 2020

Treatment Efficiency in Gaucher Patients Can Reliably Be Monitored by Quantification of Lyso-Gb1 Concentrations in Dried Blood Spots

Biomarkers are key tools in establishing a diagnosis and monitoring rare disorders. The lipid metabolite Lyso-Gb1 has long been known as an excellent diagnostic biomarker. In a recent study, which was initiated and led by researchers at CENTOGENE, Lyso-Gb1 was shown to also be ideally suited for monitoring purposes. The findings were published in the International Journal of Molecular Sciences.